Global Contrast Media Injectors Market - Which segment to grow at the highest CAGR?
The global contrast media injectors market
 is expected to reach USD 636.1 million by 2021. Factors such as 
increasing number of approvals for contrast agents, increasing number of
 public and private diagnostic centers, technological advancements in 
the contrast media injector arena and the increased focus of market 
players in the injector technology provide high growth opportunities for
 players in the global contrast media injectors market.
Interventional cardiology segment to grow at the highest CAGR during the forecast period
On the basis of application, the global contrast media injectors market 
is segmented into interventional radiology, and interventional 
cardiology applications. The radiology segment is expected to account 
for the largest share of the global contrast media injectors market 
whereas the interventional cardiology segment is expected to grow at the
 highest CAGR. The growth of the market can be attributed to the high 
global CVD burden. According to the World Heart Federation (WHF), by 
2030, nearly 23.6 million people are predicted to die worldwide from 
CVD. This is leading to an increase in the demand for cardiac 
intervention procedures and coronary diagnostic procedures.
Key
 players in the global contrast injectors market include Bracco Imaging 
S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), 
Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare 
(U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino 
Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and
 Apollo RT Co., Ltd. (China). 
Comments
Post a Comment